Pharmacokinetics of a SARS-CoV-2 Monoclonal Antibody in Hematopoietic Stem Cell Transplant Recipients (COVIDMAB)
Latest Information Update: 12 Jun 2023
At a glance
- Drugs Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms COVIDMAB
- 12 Jan 2023 Planned End Date changed from 15 Jan 2023 to 15 Jan 2024.
- 12 Jan 2023 Planned primary completion date changed from 15 Jan 2023 to 15 Jan 2024.
- 06 Jun 2022 Planned number of patients changed from 50 to 55.